Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fnut.2026.1788810.s001IntroductionEscherichia coli (E. coli) is a common foodborne pathogen that can cause various infections such as diarrhea and meningitis.MethodsIn this study, 38 Bifidobacterium strains isolated from healthy breastfed infants were evaluated in vitro. D2, which demonstrated the strongest antagonism against E. coli and the most favorable probiotic properties, was selected for further investigation in vivo. The acid removal experiment of the cell-free supernatant (CFS) of D2 was conducted. Animal experiments were also performed, comparing D2 with A14 (a strain showing no antibacterial effect in vitro).ResultsAcetic acid was identified as the main antibacterial substance in the CFS of D2 (P DiscussionThese results indicate that D2 inhibits E. coli through multiple target points and represents a potential candidate strain for alleviating intestinal disorders caused by E. coli, or an alternative to antibiotics.
Keyword(s):
antibacterial mechanism; bifidobacterium; Clinical and Sports Nutrition; gut microbiota; intestinal disorder.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)